DEA's 2nd Annual Supply Chain Conference

April 30-May 2, 2024

Little Rock, Arkansas

The Drug Enforcement Administration (DEA), Diversion Control Division, hosted a Supply Chain Conference April 30-May 2, 2024, at the Four Points by Sheraton, Little Rock, Arkansas. This conference offered DEA registered Manufacturers, Distributors, Pharmacists, Importers or Exporters the opportunity to meet, share information and discuss concerns.

The conference provided a venue in which representatives from the supply chain industry, their affiliated associations, and DEA engaged in discussions concerning existing federal regulations, issues requiring regulatory changes, clarification of DEA policy, and the development of initiatives to reduce diversion of pharmaceutical controlled substances while ensuring an adequate and uninterrupted supply.

Tuesday, April 30, 2024 (DAY 1)
General Session

IT Transformation (Website, CONTACT center, Registrant Survey)
Matthew Strait, Deputy Assistant Administrator, Policy
Marsha Ikner, Acting Deputy Assistant Administrator, Regulatory
Hyun Choe, Supervisor Information Technology Specialist

Registration Program Overview & Updates
Holly Farrington, Program Analyst, Registration and Program Support

MOUD Update & Take Back - Disposal/Authorized Collectors
Matthew Strait, Deputy Assistant Administrator

Substance and Chemical Controls and Related Issues
Dr. Terrence Boos, Section Chief, Drug and Chemical Evaluation Section

Regulatory Drafting Priorities & Policy Updates
Alana Moore, Unit Chief, Drafting and Policy Support Section
Danielle Staley, Policy Analyst, Drafting and Policy Support Section

ARCOS Reporting
Samuel Weisman, Data Systems Analyst, Reports Analysis Unit Ghana Giles, Program Analyst, Reports Analysis Unit

Wednesday, May 1, 2025 (DAY 2)
Quotas and Import/Export

International Drug Treaties and the CSA
Stacy Harper-Avilla, Section Chief, UN Reporting and Quota Section

Quotas - Aggregate Production & Individual Quotas
Kitty Chung, Drug Science Specialist, UN Reporting and Quota Section

Quotas - Online Applications Changes
Gregory Kavanagh, Drug Science Specialist, UN Reporting and Quota Section

Research vs Manufacturing
Minh Dang, Drug Science Specialist, UN Reporting and Quota Section

Quotas - Year End Reporting
Mark Cunningham, Drug Science Specialist, UN Reporting and Quota Section

The 303 Process - Best Practices
Ricardo Quintero, Section Chief, Regulatory Section
Brenda Thomas, Program Analyst, Regulatory Section

Imports and Exports of Controlled Substances and Listed Chemicals
Jacob Prieto, Section Chief, Import/Export Section

New Application Features: Import/Export of Controlled Substances
Thomas Fahmy, Program Analyst, Import/Export Section

Permit Applications/Declarations Process
Aaronita Perry, Import/Export Specialists, Import/Export Section
Barbara Clacks, Import/Export Specialists, Import/Export Section
Jacob Prieto, Section Chief, Import/Export Section

Regulated machines
Thomas Fahmy, Program Analyst, Import/Export Section

Thursday, May 2, 2024 (DAY 3)
Industry Trends

Preparing for a DEA Inspection: What to expect and how to better prevent diversion
Niketa Prince, Staff Coordinator, Liaison Section

Pharmacy Security
Irvin Reaves, Group Supervisor, Little Rock Diversion Group

DEA Reporting Requirements & Reporting Tools: DTL & SORS
June Howard, Unit Chief, Reports Analysis Unit

Drug Shortages
Matthew Strait, Deputy Assistant Administrator